Replies to post #186502 on Biotech Values

[DewDiligence]

JNJ at EASL:

http://finance.yahoo.com/news/janssen-highlights-hepatitis-c-virus-080000232.html

Early-stage data on the investigational nucleotide analog polymerase inhibitors AL-335 and AL-516, which were recently obtained through Janssen’s acquisition of Alios BioPharma, will also be presented.

Not likely to cause a rush of investor excitement.